ABOUT US

Mission History Boards of Directors Staff Join PPTA

MEMBER COMPANIES ISSUES

U.S.

Federal State Regulatory

European Union

Patient Access & Health Policy Institutions EU Member States

Other Countries

Organizations and Institutions

International

International Institutions

PLASMA & THERAPIES

Plasma & Blood Become a Donor Find a Donation Center FAQ Diseases Therapies

PROGRAMS & STANDARDS

Donor Deferral (NDDR) Patient Notification System IQPP QSEAL Data Center

NEW! PPTA DHQ PATIENT RESOURCES

Learn About Patients Patient Groups Patient Notification System Resources IVIG Manufacturers

PUBLICATIONS

The Source

This Season's Issue Why Subscribe? Subscription / Order Center Email the Editor Advertising Opportunities

Fact Sheets Brochures

NEWSROOM

Calendar of Events Press Releases Industry Facts Videos Press Contacts Subscribe to e-releases

CONTACT

PATIENT NOTIFICATION SYSTEM
Confidential notification within 24 hours of therapy withdrawals & recalls

China USA/UK Spain Germany Italy Japan France

> Issues

Print Email

U.S Issues

PPTA and its member companies seek to develop and bring life saving plasma protein therapeutics to patients in a way that is expeditious, maximizes patient access and encourages continued innovation. While these goals might seem uncomplicated on the surface, achieving them requires a complex, delicately balanced legal and regulatory environment at every level from state and local to federal. PPTA is the leading industry voice at all those levels.

Federal Issues

State Issues

Regulatory Issues